Leiden, the Netherlands, June 11, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that…
Press release Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of…